Shares of Sun Pharma continued its gains from Friday, rising over a percent on Monday morning, after its Halol plant received a VAI status from US drug regulator.
The status implies that the plant may not go a re-inspection by the regulator ahead. The stock has touched an intraday high of Rs 536.00 and an intraday low of Rs 527.70.
The company has received a voluntary action initiated status for its Halol plant from US FDA. For the uninitiated, VAI status would imply that there would be no re-inspection required at its Halol unit.
The status implies that the plant may not go a re-inspection by the regulator ahead. The stock has touched an intraday high of Rs 536.00 and an intraday low of Rs 527.70.
The company has received a voluntary action initiated status for its Halol plant from US FDA. For the uninitiated, VAI status would imply that there would be no re-inspection required at its Halol unit.
No comments:
Post a Comment